×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 10 – Real World Evidence – A True Snapshot of Benefit and Risk
Session Chair(s)
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States
Speaker(s)
Exploring New Methods for Pharmacovigilance
Nancy A Dreyer, PhD, MPH, FISPE
Dreyer Strategies LLC, United States
Founder
Anonymized Datasets from Multiple Organizations: Potential for Use in Epidemiology and Signal Detection
Andres Gomez, PhD, MPH
Bristol-Myers Squibb, United States
Vice President, Head of Epidemiology, Safety Science, and Analytics
Benefits and Harms of "Real World" Evidence: Should We Be Changing Our Views?
Stephen JW Evans, MSc, FRCP
The London School of Hygiene & Tropical Medicine, United Kingdom
Professor of Pharmacoepidemiology
Have an account?